Research Suggests New Direction For ALS Treatment

A research team from Wake Forest University School of Medicine is the first to show that injections of a protein normally found in human cells can increase lifespan and delay the onset of symptoms in mice with ALS (amyotrophic lateral sclerosis), or Lou Gehrig’s disease. Reporting in the Nov. [click link for full article]

More: continued here

Filed under: Muscular Dystrophy on December 2nd, 2007